FeesSafety
Pluang+

FactSet integrates 500+ alternative data assets via Carbon Arc to boost AI-driven investment insights.

Market News
10 Nov 2026, 19:01 WIB
GlobeNewsWire
View Source
Bullish
FactSet integrates 500+ alternative data assets via Carbon Arc to boost AI-driven investment insights.

FactSet has partnered with Carbon Arc to embed over 500 alternative data assets from more than 60 providers into its Workstation and Model Context Protocol platforms. This integration offers investment professionals enhanced access to diverse data sets like credit card transactions, retail foot traffic, and ecommerce trends, enabling better market analysis and early detection of shifts in consumer demand. The partnership also supports seamless workflow integration and AI-ready intelligence, helping clients leverage advanced AI tools for faster, more actionable insights across industries and geographies. This move strengthens FactSet's position as a leading provider of comprehensive financial and alternative data solutions.

FactSet's new partnership with Carbon Arc is highlighted here alongside market data for Technology-sector stocks on Pluang. For readers following this sector, as of Nov 10, 2026 23:02 WIB, out of 150 priced US technology stocks, 44 rose and 103 fell. Notable movers include EXFY at USD 1.70 with a 1-day change of -8.11%, AXTI at USD 39.45 down 8.06%, and TTWO at USD 223.78 up 7.90%, with typical hold times ranging from 19 to 115 days and mixed Pluang order activity.

More News

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
1 hour ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
2 hours ago
Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...

Market News
Bullish
2 hours ago
MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore introduced the AdSense Policy Grader, an AI-powered tool that audits websites for compliance with Google's ad policies to prevent account bans and revenue loss. The tool offers a free basic report and a detailed paid report covering 79 p...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App